Sino Biopharmaceutical Limited (1177.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Sino Biopharmaceutical Limited, with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 42.70x |
| P/B Ratio | 3.27x |
| P/S Ratio | 3.15x |
| Profitability | |
| Gross Margin | 82.1% |
| Operating Margin | 21.8% |
| Net Margin | 7.4% |
| EBITDA Margin | 22.8% |
| Liquidity | |
| Current Ratio | 1.37x |
| Quick Ratio | 1.28x |
| Leverage | |
| Debt/Equity | 0.52x |
YoY = year-over-year change. Source: FMP..